| |
| |
|
| Insider
Information: |
Bancel Stephane |
| Relationship: |
Chief Executive Office... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
5,631,371 |
|
|
Indirect Shares
|
15,615,252 |
|
|
| Direct
Value |
$261,491 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,246,623 |
|
|
| Total
Value |
$261,491 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bg Medicine, Inc. |
BGMD |
Executive Chairman, Di... |
2012-11-15 |
123,167 |
2011-09-08 |
0 |
Premium* |
|
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director |
2016-07-06 |
47,980 |
|
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Chief Executive Office... |
2024-02-16 |
5,460,224 |
2024-02-16 |
15,615,252 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
672 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 27
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2011-09-08 |
4 |
B |
$4.40 |
$17,600 |
D/D |
4,000 |
4,000 |
2.81 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2011-09-09 |
4 |
B |
$4.30 |
$17,200 |
D/D |
4,000 |
8,000 |
2.81 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2011-09-12 |
4 |
B |
$3.63 |
$21,767 |
D/D |
6,000 |
14,000 |
2.81 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2012-02-22 |
4 |
B |
$0.00 |
$0 |
D/D |
2,778 |
16,778 |
2.73 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2012-05-17 |
4 |
B |
$3.84 |
$19,231 |
D/D |
5,008 |
21,786 |
2.81 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2012-09-13 |
4 |
B |
$3.70 |
$5,110 |
D/D |
1,381 |
23,167 |
2.81 |
- |
|
| BGMD |
Bg Medicine, Inc. |
Executive Chairman |
• • – |
2012-11-15 |
4 |
B |
$1.26 |
$126,000 |
D/D |
100,000 |
123,167 |
2.81 |
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2016-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
21,314 |
|
- |
|
| SYRS |
Syros Pharmaceuticals, In... |
Director |
– • – |
2016-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,666 |
47,980 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2018-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
13,830,496 |
7,974,603 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-11-01 |
4 |
AS |
$15.66 |
$177,570 |
I/I |
(11,046) |
905,788 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-11-08 |
4 |
AS |
$17.38 |
$191,979 |
I/I |
(11,046) |
894,742 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-11-15 |
4 |
AS |
$19.02 |
$210,216 |
I/I |
(11,046) |
883,696 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-11-22 |
4 |
AS |
$20.48 |
$226,222 |
I/I |
(11,046) |
872,650 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-11-29 |
4 |
AS |
$20.54 |
$226,885 |
I/I |
(11,046) |
861,604 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-12-06 |
4 |
AS |
$19.42 |
$221,081 |
I/I |
(11,046) |
850,558 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,132 |
6,762,500 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-12-13 |
4 |
AS |
$18.53 |
$204,682 |
I/I |
(11,046) |
839,512 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-12-20 |
4 |
AS |
$19.69 |
$217,496 |
I/I |
(11,046) |
828,466 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2019-12-27 |
4 |
AS |
$19.53 |
$215,728 |
I/I |
(11,046) |
817,420 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-01-02 |
4 |
AS |
$19.57 |
$100,081 |
I/I |
(5,114) |
9,247,413 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-01-03 |
4 |
AS |
$19.04 |
$210,316 |
I/I |
(11,046) |
806,374 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-01-10 |
4 |
AS |
$19.60 |
$333,582 |
I/I |
(16,482) |
9,244,695 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,989 |
6,757,511 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Chief Executive Officer |
• • – |
2020-01-21 |
4 |
AS |
$20.79 |
$100,832 |
I/I |
(4,850) |
9,242,270 |
0 |
- |
|
672 Records found
|
|
Page 1 of 27 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
